H.B. 100

1

AMENDMENTS TO PRESCRIBING SCHEDULE
2 II DRUGS
3 2008 GENERAL SESSION
4 STATE OF UTAH
5 Chief Sponsor: Mark A. Wheatley
6 Senate Sponsor: ____________
7
8 LONG TITLE
9 General Description:
10 This bill amends the Utah Controlled Substances Act.
11 Highlighted Provisions:
12 This bill:
13 . changes the maximum supply of a controlled substance that may be prescribed at
14 one time from a 30 day supply to a 90 day supply; and
15 . removes the authority to distribute three different post dated prescriptions for the
16 same controlled substance.
17 Monies Appropriated in this Bill:
18 None
19 Other Special Clauses:
20 None
21 Utah Code Sections Affected:
22 AMENDS:
23 58-37-6, as last amended by Laws of Utah 2006, Chapters 21 and 281
24
25 Be it enacted by the Legislature of the state of Utah:
26 Section 1. Section 58-37-6 is amended to read:
27 58-37-6. License to manufacture, produce, distribute, dispense, administer, or

28 conduct research -- Issuance by division -- Denial, suspension, or revocation -- Records
29 required -- Prescriptions.
30 (1) (a) The division may adopt rules relating to the licensing and control of the
31 manufacture, distribution, production, prescription, administration, dispensing, conducting of
32 research with, and performing of laboratory analysis upon controlled substances within this
33 state.
34 (b) The division may assess reasonable fees to defray the cost of issuing original and
35 renewal licenses under this chapter pursuant to Section 63-38-3.2 .
36 (2) (a) (i) Every person who manufactures, produces, distributes, prescribes, dispenses,
37 administers, conducts research with, or performs laboratory analysis upon any controlled
38 substance in Schedules II through V within this state, or who proposes to engage in
39 manufacturing, producing, distributing, prescribing, dispensing, administering, conducting
40 research with, or performing laboratory analysis upon controlled substances included in
41 Schedules II through V within this state shall obtain a license issued by the division.
42 (ii) The division shall issue each license under this chapter in accordance with a
43 two-year renewal cycle established by rule. The division may by rule extend or shorten a
44 renewal period by as much as one year to stagger the renewal cycles it administers.
45 (b) Persons licensed to manufacture, produce, distribute, prescribe, dispense,
46 administer, conduct research with, or perform laboratory analysis upon controlled substances in
47 Schedules II through V within this state may possess, manufacture, produce, distribute,
48 prescribe, dispense, administer, conduct research with, or perform laboratory analysis upon
49 those substances to the extent authorized by their license and in conformity with this chapter.
50 (c) The following persons are not required to obtain a license and may lawfully possess
51 controlled substances under this section:
52 (i) an agent or employee, except a sales representative, of any registered manufacturer,
53 distributor, or dispenser of any controlled substance, if the agent or employee is acting in the
54 usual course of his business or employment; however, nothing in this subsection shall be
55 interpreted to permit an agent, employee, sales representative, or detail man to maintain an
56 inventory of controlled substances separate from the location of his employer's registered and
57 licensed place of business;
58 (ii) a motor carrier or warehouseman, or an employee of a motor carrier or

59 warehouseman, who possesses any controlled substance in the usual course of his business or
60 employment; and
61 (iii) an ultimate user, or any person who possesses any controlled substance pursuant to
62 a lawful order of a practitioner.
63 (d) The division may enact rules waiving the license requirement for certain
64 manufacturers, producers, distributors, prescribers, dispensers, administrators, research
65 practitioners, or laboratories performing analysis if consistent with the public health and safety.
66 (e) A separate license is required at each principal place of business or professional
67 practice where the applicant manufactures, produces, distributes, dispenses, conducts research
68 with, or performs laboratory analysis upon controlled substances.
69 (f) The division may enact rules providing for the inspection of a licensee or applicant's
70 establishment, and may inspect the establishment according to those rules.
71 (3) (a) Upon proper application, the division shall license a qualified applicant to
72 manufacture, produce, distribute, conduct research with, or perform laboratory analysis upon
73 controlled substances included in Schedules I through V, unless it determines that issuance of a
74 license is inconsistent with the public interest. The division shall not issue a license to any
75 person to prescribe, dispense, or administer a Schedule I controlled substance. In determining
76 public interest, the division shall consider whether or not the applicant has:
77 (i) maintained effective controls against diversion of controlled substances and any
78 Schedule I or II substance compounded from any controlled substance into other than
79 legitimate medical, scientific, or industrial channels;
80 (ii) complied with applicable state and local law;
81 (iii) been convicted under federal or state laws relating to the manufacture, distribution,
82 or dispensing of substances;
83 (iv) past experience in the manufacture of controlled dangerous substances;
84 (v) established effective controls against diversion; and
85 (vi) complied with any other factors that the division establishes that promote the
86 public health and safety.
87 (b) Licenses granted under Subsection (3)(a) do not entitle a licensee to manufacture,
88 produce, distribute, conduct research with, or perform laboratory analysis upon controlled
89 substances in Schedule I other than those specified in the license.

90 (c) (i) Practitioners shall be licensed to administer, dispense, or conduct research with
91 substances in Schedules II through V if they are authorized to administer, dispense, or conduct
92 research under the laws of this state.
93 (ii) The division need not require a separate license for practitioners engaging in
94 research with nonnarcotic controlled substances in Schedules II through V where the licensee is
95 already licensed under this act in another capacity.
96 (iii) With respect to research involving narcotic substances in Schedules II through V,
97 or where the division by rule requires a separate license for research of nonnarcotic substances
98 in Schedules II through V, a practitioner shall apply to the division prior to conducting
99 research.
100 (iv) Licensing for purposes of bona fide research with controlled substances by a
101 practitioner considered qualified may be denied only on a ground specified in Subsection (4),
102 or upon evidence that the applicant will abuse or unlawfully transfer or fail to safeguard
103 adequately his supply of substances against diversion from medical or scientific use.
104 (v) Practitioners registered under federal law to conduct research in Schedule I
105 substances may conduct research in Schedule I substances within this state upon furnishing the
106 division evidence of federal registration.
107 (d) Compliance by manufacturers, producers, and distributors with the provisions of
108 federal law respecting registration, excluding fees, entitles them to be licensed under this
109 chapter.
110 (e) The division shall initially license those persons who own or operate an
111 establishment engaged in the manufacture, production, distribution, dispensation, or
112 administration of controlled substances prior to April 3, 1980, and who are licensed by the
113 state.
114 (4) (a) Any license pursuant to Subsection (2) or (3) may be denied, suspended, placed
115 on probation, or revoked by the division upon finding that the applicant or licensee has:
116 (i) materially falsified any application filed or required pursuant to this chapter;
117 (ii) been convicted of an offense under this chapter or any law of the United States, or
118 any state, relating to any substance defined as a controlled substance;
119 (iii) been convicted of a felony under any other law of the United States or any state
120 within five years of the date of the issuance of the license;

121 (iv) had a federal license denied, suspended, or revoked by competent federal authority
122 and is no longer authorized to engage in the manufacturing, distribution, or dispensing of
123 controlled substances;
124 (v) had his license suspended or revoked by competent authority of another state for
125 violation of laws or regulations comparable to those of this state relating to the manufacture,
126 distribution, or dispensing of controlled substances;
127 (vi) violated any division rule that reflects adversely on the licensee's reliability and
128 integrity with respect to controlled substances;
129 (vii) refused inspection of records required to be maintained under this chapter by a
130 person authorized to inspect them; or
131 (viii) prescribed, dispensed, administered, or injected an anabolic steroid for the
132 purpose of manipulating human hormonal structure so as to:
133 (A) increase muscle mass, strength, or weight without medical necessity and without a
134 written prescription by any practitioner in the course of his professional practice; or
135 (B) improve performance in any form of human exercise, sport, or game.
136 (b) The division may limit revocation or suspension of a license to a particular
137 controlled substance with respect to which grounds for revocation or suspension exist.
138 (c) (i) Proceedings to deny, revoke, or suspend a license shall be conducted pursuant to
139 this section and in accordance with the procedures set forth in Title 58, Chapter 1, Division of
140 Occupational and Professional Licensing Act, and conducted in conjunction with the
141 appropriate representative committee designated by the director of the department.
142 (ii) Nothing in this Subsection (4)(c) gives the Division of Occupational and
143 Professional Licensing exclusive authority in proceedings to deny, revoke, or suspend licenses,
144 except where the division is designated by law to perform those functions, or, when not
145 designated by law, is designated by the executive director of the Department of Commerce to
146 conduct the proceedings.
147 (d) (i) The division may suspend any license simultaneously with the institution of
148 proceedings under this section if it finds there is an imminent danger to the public health or
149 safety.
150 (ii) Suspension shall continue in effect until the conclusion of proceedings, including
151 judicial review, unless withdrawn by the division or dissolved by a court of competent

152 jurisdiction.
153 (e) (i) If a license is suspended or revoked under this Subsection (4), all controlled
154 substances owned or possessed by the licensee may be placed under seal in the discretion of the
155 division.
156 (ii) Disposition may not be made of substances under seal until the time for taking an
157 appeal has lapsed, or until all appeals have been concluded, unless a court, upon application,
158 orders the sale of perishable substances and the proceeds deposited with the court.
159 (iii) If a revocation order becomes final, all controlled substances shall be forfeited.
160 (f) The division shall notify promptly the Drug Enforcement Administration of all
161 orders suspending or revoking a license and all forfeitures of controlled substances.
162 (5) (a) Persons licensed under Subsection (2) or (3) shall maintain records and
163 inventories in conformance with the record keeping and inventory requirements of federal and
164 state law and any additional rules issued by the division.
165 (b) (i) Every physician, dentist, veterinarian, practitioner, or other person who is
166 authorized to administer or professionally use a controlled substance shall keep a record of the
167 drugs received by him and a record of all drugs administered, dispensed, or professionally used
168 by him otherwise than by a prescription.
169 (ii) A person using small quantities or solutions or other preparations of those drugs for
170 local application has complied with this Subsection (5)(b) if he keeps a record of the quantity,
171 character, and potency of those solutions or preparations purchased or prepared by him, and of
172 the dates when purchased or prepared.
173 (6) Controlled substances in Schedules I through V may be distributed only by a
174 licensee and pursuant to an order form prepared in compliance with division rules or a lawful
175 order under the rules and regulations of the United States.
176 (7) (a) A person may not write or authorize a prescription for a controlled substance
177 unless he is:
178 (i) a practitioner authorized to prescribe drugs and medicine under the laws of this state
179 or under the laws of another state having similar standards; and
180 (ii) licensed under this chapter or under the laws of another state having similar
181 standards.
182 (b) A person other than a pharmacist licensed under the laws of this state, or his

183 licensed intern, as required by Sections 58-17b-303 and 58-17b-304 , may not dispense a
184 controlled substance.
185 (c) (i) A controlled substance may not be dispensed without the written prescription of
186 a practitioner, if the written prescription is required by the federal Controlled Substances Act.
187 (ii) That written prescription shall be made in accordance with Subsection (7)(a) and in
188 conformity with Subsection (7)(d).
189 (iii) In emergency situations, as defined by division rule, controlled substances may be
190 dispensed upon oral prescription of a practitioner, if reduced promptly to writing on forms
191 designated by the division and filed by the pharmacy.
192 (iv) Prescriptions reduced to writing by a pharmacist shall be in conformity with
193 Subsection (7)(d).
194 (d) Except for emergency situations designated by the division, a person may not issue,
195 fill, compound, or dispense a prescription for a controlled substance unless the prescription is
196 signed by the prescriber in ink or indelible pencil or is signed with an electronic signature of
197 the prescriber as authorized by division rule, and contains the following information:
198 (i) the name, address, and registry number of the prescriber;
199 (ii) the name, address, and age of the person to whom or for whom the prescription is
200 issued;
201 (iii) the date of issuance of the prescription; and
202 (iv) the name, quantity, and specific directions for use by the ultimate user of the
203 controlled substance.
204 (e) A prescription may not be written, issued, filled, or dispensed for a Schedule I
205 controlled substance.
206 (f) Except when administered directly to an ultimate user by a licensed practitioner,
207 controlled substances are subject to the following restrictions:
208 (i) (A) A prescription for a Schedule II substance may not be refilled.
209 (B) A Schedule II controlled substance may not be filled in a quantity to exceed a
210 [one-month's] 90 day supply, as directed on the daily dosage rate of the prescriptions.
211 (ii) A Schedule III or IV controlled substance may be filled only within six months of
212 issuance, and may not be refilled more than six months after the date of its original issuance or
213 be refilled more than five times after the date of the prescription unless renewed by the

214 practitioner.
215 (iii) All other controlled substances in Schedule V may be refilled as the prescriber's
216 prescription directs, but they may not be refilled one year after the date the prescription was
217 issued unless renewed by the practitioner.
218 (iv) Any prescription for a Schedule II substance may not be dispensed if it is not
219 presented to a pharmacist for dispensing by a pharmacist or a pharmacy intern within 30 days
220 after the date the prescription was issued, or 30 days after the dispensing date, if that date is
221 specified separately from the date of issue.
222 [(v) A practitioner may issue more than one prescription at the same time for the same
223 Schedule II controlled substance, but only under the following conditions:]
224 [(A) no more than three prescriptions for the same Schedule II controlled substance
225 may be issued at the same time;]
226 [(B) no one prescription may exceed a 30-day supply;]
227 [(C) a second or third prescription shall include the date of issuance and the date for
228 dispensing; and]
229 [(D) unless the practitioner determines there is a valid medical reason to the contrary,
230 the date for dispensing a second or third prescription may not be fewer than 30 days from the
231 dispensing date of the previous prescription.]
232 [(vi)] (v) Each prescription for a controlled substance may contain only one controlled
233 substance per prescription form and may not contain any other legend drug or prescription
234 item.
235 (g) An order for a controlled substance in Schedules II through V for use by an
236 inpatient or an outpatient of a licensed hospital is exempt from all requirements of this
237 Subsection (7) if the order is:
238 (i) issued or made by a prescribing practitioner who holds an unrestricted registration
239 with the federal Drug Enforcement Administration, and an active Utah controlled substance
240 license in good standing issued by the division under this section, or a medical resident who is
241 exempted from licensure under Subsection 58-1-307 (1)(c);
242 (ii) authorized by the prescribing practitioner treating the patient and the prescribing
243 practitioner designates the quantity ordered;
244 (iii) entered upon the record of the patient, the record is signed by the prescriber

245 affirming his authorization of the order within 48 hours after filling or administering the order,
246 and the patient's record reflects the quantity actually administered; and
247 (iv) filled and dispensed by a pharmacist practicing his profession within the physical
248 structure of the hospital, or the order is taken from a supply lawfully maintained by the hospital
249 and the amount taken from the supply is administered directly to the patient authorized to
250 receive it.
251 (h) A practitioner licensed under this chapter may not prescribe, administer, or
252 dispense a controlled substance to a child, without first obtaining the consent required in
253 Section 78-14-5 of a parent, guardian, or person standing in loco parentis of the child except in
254 cases of an emergency. For purposes of this Subsection (7)(h), "child" has the same meaning
255 as defined in Section 78-3a-103 , and "emergency" means any physical condition requiring the
256 administration of a controlled substance for immediate relief of pain or suffering.
257 (i) A practitioner licensed under this chapter may not prescribe or administer dosages
258 of a controlled substance in excess of medically recognized quantities necessary to treat the
259 ailment, malady, or condition of the ultimate user.
260 (j) A practitioner licensed under this chapter may not prescribe, administer, or dispense
261 any controlled substance to another person knowing that the other person is using a false name,
262 address, or other personal information for the purpose of securing the controlled substance.
263 (k) A person who is licensed under this chapter to manufacture, distribute, or dispense
264 a controlled substance may not manufacture, distribute, or dispense a controlled substance to
265 another licensee or any other authorized person not authorized by this license.
266 (l) A person licensed under this chapter may not omit, remove, alter, or obliterate a
267 symbol required by this chapter or by a rule issued under this chapter.
268 (m) A person licensed under this chapter may not refuse or fail to make, keep, or
269 furnish any record notification, order form, statement, invoice, or information required under
270 this chapter.
271 (n) A person licensed under this chapter may not refuse entry into any premises for
272 inspection as authorized by this chapter.
273 (o) A person licensed under this chapter may not furnish false or fraudulent material
274 information in any application, report, or other document required to be kept by this chapter or
275 willfully make any false statement in any prescription, order, report, or record required by this

276 chapter.
277 (8) (a) (i) Any person licensed under this chapter who is found by the division to have
278 violated any of the provisions of Subsections (7)(k) through (7)(o) is subject to a penalty not to
279 exceed $5,000. The division shall determine the procedure for adjudication of any violations in
280 accordance with Sections 58-1-106 and 58-1-108 .
281 (ii) The division shall deposit all penalties collected under Subsection (8)(a)(i) in the
282 General Fund as a dedicated credit to be used by the division under Subsection 58-37-7.7 (1).
283 (b) Any person who knowingly and intentionally violates Subsections (7)(h) through
284 (7)(j) is:
285 (i) upon first conviction, guilty of a class B misdemeanor;
286 (ii) upon second conviction, guilty of a class A misdemeanor; and
287 (iii) on third or subsequent conviction, guilty of a third degree felony.
288 (c) Any person who knowingly and intentionally violates Subsections (7)(k) through
289 (7)(o) shall upon conviction be guilty of a third degree felony.
290 (9) Any information communicated to any licensed practitioner in an attempt to
291 unlawfully procure, or to procure the administration of, a controlled substance is not considered
292 to be a privileged communication.




Legislative Review Note
as of 12-10-07 6:54 AM

Office of Legislative Research and General Counsel